David Loven

1.1k citations
38 papers · 844 indexed · h-index 16

Impact in

  • Oncology top 10%
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers
  • Genetics top 10%
    • Glioma Diagnosis and Treatment

Papers in

    • Vascular Tumors and Angiosarcomas 3
    • Cancer Cells and Metastasis 3
    • Glioma Diagnosis and Treatment 5

David Loven

38 papers receiving 822 citations

Peers

David Loven
Comparison fields: 5 of 79
  • Oncology 377
  • Genetics 111
  • Cancer Research 109
  • Immunology 147
  • Neurology 101
Replace Hyun Jung Jun with:
Hyun Jung Jun South Korea
Katsuhiko Matsuo Japan
M.J. Requena Spain
Monica Girotra United States
Ahmed Younes United States
Magdalena Chechlińska Poland
Agnese Barnabei Italy
Martina Imbimbo Italy
Anthony J. Jaslowski United States
Christine Lévy France
David Loven relative to Hyun Jung Jun South Korea Hyun Jung Jun's profile →
Citations per field
00.5×1.5×
Hyun Jung Jun · 1×
Citations per year

Countries citing papers authored by David Loven

Since Specialization
Citations

This map shows the geographic impact of David Loven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Loven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Loven more than expected).

Fields of papers citing papers by David Loven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Loven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Loven. The network helps show where David Loven may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Loven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Loven Line = papers co-authored together David Loven links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202015
2 201691
3 201313
4 201199
5 200837
6 200713
7 200613
8 200627
9 200632
10 200422
11 200466
12 200118
13 200113
14 199810
15 199424
16 199435
17 199452
18 19918
19 199115
20 199010

About David Loven

David Loven is a scholar working on Oncology, Genetics, Cancer Research, Neurology and Dermatology, having authored 38 papers that have together received 844 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), Meningioma and schwannoma management (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Vascular Tumors and Angiosarcomas (3 papers), Brain Metastases and Treatment (3 papers), Cancer Cells and Metastasis (3 papers), Extracellular vesicles in disease (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (377 citations), Genetics (111 citations), Cancer Research (109 citations), Immunology (147 citations) and Neurology (101 citations). David Loven has collaborated with scholars based in Israel, Switzerland and Italy. Frequent co-authors include Yuval Shaked, Francesco Bertolini, Z. Harry Rappaport, Dror Alishekevitz, Svetlana Gingis‐Velitski, Tali Voloshin, Erez Hasnis, H. Lurie, Aarón Sulkes and Eyal Fenig. Their work appears in journals such as Cancer, Neurosurgery, Journal of neurosurgery, Molecular Cancer Therapeutics and Child s Nervous System.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026